The role of EGFR upregulation in tumor development and progression through the mechanism of tumor angiogenesis has been demonstrated in several tumors, for instance non-small-cell lung cancer, head and neck, pancreatic, colorectal, breast, and brain cancers [113,114,115]. Here, EGFR is linked to non-small cell lung carcinoma.